However, in HER2-positive breast cancer cells cocultured with human peripheral blood mononuclear cells and in a mouse model, trastuzumab anti-HER2 therapy resulted in upregulation of PD-L175,76. The gene discussed is ERBB2; the disease is breast cancer.